Real-time enrollment status for this hematopoietic and lymphatic system neoplasm clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 7:18 PM UTC
| NCT Number | NCT07025538 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Phase | PHASE1 |
| Target Enrollment | 42 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | July 13, 2026 (Jul 13, 2026) |
As of September 2, 2026: Clinical trial NCT07025538 is currently recruiting participants. This phase1 study for hematopoietic and lymphatic system neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07025538 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07025538 was last updated Jul 13, 2026 (July 13, 2026). HelloStudys verifies this status automatically.